- Supplementary Figure 1[supplements/250872_file02.gif]
- Supplementary Figure 2[supplements/250872_file03.gif]
- Supplementary Figure 3[supplements/250872_file04.gif]
- Supplementary Figure 4[supplements/250872_file05.gif]
- Supplementary Animation 1[supplements/250872_file06.mp4]
- Supplementary Animation 2[supplements/250872_file07.mp4]
![[supplements/250872_file02.gif]](https://www.medrxiv.org/content/medrxiv/early/2021/02/03/2021.01.31.21250872/DC1/embed/media-1.gif?download=true){kind=link}
![[supplements/250872_file03.gif]](https://www.medrxiv.org/content/medrxiv/early/2021/02/03/2021.01.31.21250872/DC2/embed/media-2.gif?download=true){kind=link}
![[supplements/250872_file04.gif]](https://www.medrxiv.org/content/medrxiv/early/2021/02/03/2021.01.31.21250872/DC3/embed/media-3.gif?download=true){kind=link}
![[supplements/250872_file05.gif]](https://www.medrxiv.org/content/medrxiv/early/2021/02/03/2021.01.31.21250872/DC4/embed/media-4.gif?download=true){kind=link}
Posted February 03, 2021.
Returning to a normal life via COVID-19 vaccines in the USA: a large-scale agent-based simulation study
